Drug Profile
ZK Prog-R-B
Alternative Names: Progesterone receptor blocker ZK Prog-R-BLatest Information Update: 02 Jul 2004
Price :
$50
*
At a glance
- Originator Bayer Schering Pharma
- Class
- Mechanism of Action Progesterone receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 02 Jul 2004 No development reported - Phase-I for Cancer in Europe (unspecified route)
- 24 Jul 2001 New profile
- 24 Jul 2001 Phase-I clinical trials for Cancer in Europe (Unknown route)